# Effects of Inhaled Epinephrine on Systemic Allergic Reactions During Allergy Testing, Immunotherapy or Oral Challenges

> **NCT07038746** · PHASE1 · RECRUITING · sponsor: **Dr. George Luciuk** · enrollment: 100 (estimated)

## Conditions studied

- Hypersensitivity
- Anaphylaxis

## Interventions

- **DRUG:** Inhaled Epinephrine

## Key facts

- **NCT ID:** NCT07038746
- **Lead sponsor:** Dr. George Luciuk
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-25
- **Primary completion:** 2026-06
- **Final completion:** 2026-07
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07038746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07038746, "Effects of Inhaled Epinephrine on Systemic Allergic Reactions During Allergy Testing, Immunotherapy or Oral Challenges". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07038746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*